New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ... Jan 15
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Truvada Tablets, 200 mg/300 mg, of Gilead Sciences... Jan 15
Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV... Jan 15
-Advertisements-